CAFFEINE CITRATE

Caffeine

Reviewed by Mariam Buksh, Malcolm Battin, Robyn Wilkinson, Jean Bertram, Ranu Tamraker
July 2008
Dose and Pharmacology Newborn Drug Protocol Index Newborn Services Home Page

Management of Caffeine Citrate Administration

Description

IV preparation

Oral preparation

Prescription

Administration

Slow IV Infusion

  1. Filter during administration with a 0.22 micron Pall filter.
  2. Administer by slow IV infusion over 30 minutes using a syringe pump.
  3. Compatible with sodium chloride 0.9%, glucose 5%, glucose 10%.
  4. Do not mix with other drugs, IV solutions, blood or blood products.
  5. Do NOT mix with Parenteral Nutrition solutions.
  6. Flush tubing with sodium chloride 0.9% before and after administration.

Oral

  1. Administer with feeds. Absorption is delayed but not decreased by feeds.

Do NOT give by IM injection.

Nursing Considerations

  1. Observe IV site for signs of extravasation.
  2. Assess for signs of adverse effects.
  3. Initial treatment should be monitored by a cardiorespiratory monitor and a pulse oximeter. Once stable, discuss apnoea monitoring with doctor.
  4. Monitor apex beat, rate and rhythm regularly. Apex beat must be taken immediately prior to administration (preferably an undisturbed rate). If the apex beat is > 180/minute withhold medication and notify doctor / NS-ANP immediately. Dose may then be administered if requested by doctor/NS-ANP.
  5. Monitor respiratory rate, quality and effort.
  6. Monitor incidence of apnoea. Continue apnoea monitoring for several days after stopping caffeine.
  7. Monitor for glycosuria.
  8. May be administered orally once the baby is tolerating 50% of full oral feed volumes.

Storage

References

1 Schmidt B et al. caffeine therapy for apnoea of prematurity. NEJM 2006; 354:2112-21.
2 Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev 2001; 3:CD000140.
3 Young TE, Magnum B. Neofax 16th edition Acorn publishing (Raleigh) 2003. P178-9
4 Aranda JV, Turmen T. Methylxanthines in apnoea of prematurity. Clin Perinatol 1979: 6:87-108.
5 Roberts RJ. Methylxanthine therapy: caffeine and theophylline. In: Roberts RJ, (ed) Drug therapy in infants: Pharmacologic principles and clinical experience. Philadelphia: WB Saunders, 1984, p119-37.